Abbreviations DEDTC: sodium diethyldithiocarbamate DIC: N,N′-Diisopropylcarbodiimide EDT: ethanedithiol HATU: 2-(1H-7-aza-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate HBTU: 2-[(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate TMR: tetramethylrhodamine dye TFA: trifluoroacetic acid TIS: triisopropylsilane
Peptides were synthesized using an automatic peptide synthesizer from Protein Tecnologies PS3 PeptideSynthesizer. Peptide synthesis was performed using standard Fmoc solid-phase methods on a PAL-PEG-PS resin (0.19 mmol/g) using HBTU/HOBt (4 equiv) as coupling agent, DIEA as base (6 equiv) and DMF as solvent. The deprotection of the temporal Fmoc protecting group was performed by treating the resin with 20% piperidine in DMF solution for 20 min. For BR, after the N-terminal aspartic acid, we coupled p-ABA chromophore. 1 Lys(Alloc) side chain deprotection: The resin containing the alloc peptide (75 mg, approx. 0.015 mmol) was suspended in CH 2 Cl 2 and shaken for 1 h to ensure a good swelling. Then Pd(OAc) 2 (1 mg, 0.3 equiv), 4-methylmorpholine (16 μL, 10 equiv), PPh 3 (6 mg, 1.5 equiv), PhSiH 3 (18 μL, 10 equiv) and 1 mL CH 2 Cl 2 were added, and the mixture shaken overnight. The resin was then filtered and washed with DMF, DEDTC, DMF and CH 2 Cl 2 and dried under a nitrogen stream.
Coupling of acetic anhydride: The resin containing the peptide (50 mg, aprox. 0.01 mmol) was suspended in DMF and shaken for 1 h to ensure good swelling. A solution of acetic anhydride (20 uL, 0.2 mmol, 20 equiv), and DIEA (400 μL, 0.195 M in DMF, 0.08 mmol, 8 equiv) 1 I. Coin, M. Beyermann, M. Bienert, Nat. Protoc., 2007, 2, 3247-3256. Electronic Supplementary Material (ESI) for Chemical Science. This journal is © The Royal Society of Chemistry 2016 was added. The reaction mixture was shaken for 0.5 h. The resin was washed with DMF (3 ×, 5 min) and CH 2 Cl 2 (2 ×, 5 min).
Bromoacetic acid coupling:
The resin containing the peptide (50 mg, aprox. 0.01 mmol) was suspended in CH 2 Cl 2 and shaken for 1 h to ensure good swelling. On the other hand, bromoacetic acid (28 mg, 20 equiv) was dissolved in 630 μL CH 2 Cl 2 and cooled to 0 ºC. Diisopropylcarbodiimide (DIC, 16 μL, 10 equiv) was added, and the mixture stirred at 0 ºC for 20 min. The solid was filtered off and the filtrate was added over the resin. The suspension was shaken for 30 min. The resin was then filtered and washed with CH 2 Cl 2 .
TMR coupling: For TMR-BR(Hk)-Br, after the N-terminal aminoacid, we coupled Fmoc-6aminohexanoic acid as spacer between the peptide and the fluorophore, and finally TMR fluorophore: 5(6)-carboxytetramethylrhodamine was coupled using 3 equiv of the rhodamine (0.15 mmol, 64.5 mg), 3 equiv of HATU and 5 equiv of DIEA 0.2 M in DMF for 60 min.
Peptide cleavage/deprotection: The resin-bound peptide was treated for approximately 2 h with the following cleavage cocktails: 940 μL TFA, 25 μL EDT, 25 μL H 2 O and 10 μL TIS (1 mL of cocktail / 40 mg resin) for cysteine-containing peptides, and 900 μL TFA, 50 μL CH 2 Cl 2 , 25 μL H 2 O and 25 μL TIS (1 mL of cocktail / 40 mg resin) for the rest of the peptides.
High-Performance Liquid Chromatography (HPLC):
HPLC was performed using an Agilent 1100 series Liquid Chromatograph Mass Spectrometer system. Analytical HPLC was carried out using a Eclipse XDB-C18 analytical column (4.6 x 150 mm, 5 μm), 1 mL/min, gradient 5 to 75% B over 30 min. Purification of the peptides was performed on a semipreparative Phenomenex Luna-C18 (250 × 10 mm) reverse-phase column. The crude products were purified by reversephase (RP) HPLC, 4 mL/min, gradient 10 to 50% B over 40 min. (A: H 2 O 0.1% TFA, B: CH 3 CN 0.1% TFA) and identified as the desired peptides. GAGA-SH was isolated with an approx. yield of 17%. BR(Gly 9 )-Br: was isolated with an approx. yield of 20%. 
Synthesis of the peptide BR(Gly 9 )GAGA:
GAGA-SH (0.1 mg, 3 × 10 -5 mmol) was dissolved in deoxygenated phosphate buffer (130 μL, 10 mM, pH = 7.5). A ZnSO 4 solution (4.5 × 10 -5 mmol, 9 μL of a 5 mM solution in Milli-Q water, 1.5 eq.) was added, and the mixture was stirred at rt for 10 min under Ar. BR(Gly 9 )-Br (6 × 10 -5 mmol, 18 μL of a 3.4 mM solution in deoxygenated phosphate buffer, 2 eq.) was added, and the solution was stirred again at rt for 1 h under Ar. The product was purified by RP−HPLC, 4 mL/min, gradient 10 to 50% B over 40 min. (A: H 2 O 0.1% TFA, B: CH 3 CN 0.1% TFA, retention time = 24.3 min), and identified as BR(Gly 9 )GAGA by mass spectrometry.
Fig. S6
HPLC chromatograms of the crude (left, gradient 10 to 50% B over 40 min) and the purified BR(Gly 9 )GAGA (center, gradient 5 to 75% B over 30 min). Right) Mass spectrum of the purified peptide.
Left: t = 15.4 starting BR(Gly 9 )-Br; t = 24.9 product BR(Gly 9 )GAGA. 
Synthesis of BR(Hk)-GAGA:
GAGA-SH (0.1 mg, 3 × 10 -5 mmol) was dissolved in deoxygenated phosphate buffer (130 μL, 10 mM, pH = 7.5). A ZnSO 4 solution (4.5 × 10 -5 mmol, 9 μL of a 5 mM solution in Milli-Q water, 1.5 eq.) was added, and the mixture was stirred at rt for 10 min under Ar. BR(Hk)-Br (6 × 10 -5 mmol, 18 μL of a 3.4 mM solution in deoxygenated phosphate buffer, 2 eq.) was added, and the solution was stirred again at rt for 1 h under Ar. The product was purified by RP−HPLC, 4 mL/min, gradient 10 to 50% B over 40 min. (A: H 2 O 0.1% TFA, B: CH 3 CN 0.1% TFA, retention time = 24.3 min), and identified as product BR(Hk)GAGA by mass spectrometry. 
Synthesis of the peptide TMR-BR(Hk)GAGA
GAGA-SH (0.1 mg, 3 × 10 -5 mmol) was dissolved in deoxygenated phosphate buffer (130 μL, 10 mM, pH = 7.5). A ZnSO 4 solution (4.5 × 10 -5 mmol, 9 μL of a 5 mM solution in Milli-Q water, 1.5 eq.) was added, and the mixture was stirred at rt for 10 min under Ar. TMR-BR(Hk)-Br (6 × 10 -5 mmol, 18 μL of a 3.4 mM solution in deoxygenated phosphate buffer:CH 3 CN 1:1, 2 eq.)
was added, and the solution was stirred again at rt for 1 h under Ar. 
Miniprotein design
These models were built with MacPymol (v1.7.6.2 Enhanced for Mac OS X) using the PDB deposited structures (PDB IDs: 1YSA for GCN4, 3UXW for AT-hook and 1YUI for GAGA).
Fig. S9
Model of the simultaneous interaction of the GCN4 basic region and the GAGA motif located at adjacent major grooves: Left: with a Gly 9 linker without minor groove contacts; Right: with an AT-hook moiety inserted in the minor groove.
Oligonucleotide sequences
Double stranded (only one strand is shown) oligonucleotides used for EMSA experiments with conjugates BR(Gly 9 )GAGA and BR(Hk)GAGA were supplied by Thermo Fischer and their sequences were:
EMSA experiments
EMSAs were performed with a BioRad Mini Protean gel system, powered by an electrophoresis power supplies PowerPac Basic model, maximum power 150 V, frequency 50-60 Hz at 140 V (constant V). Binding reactions were performed over 30 min in 18 mM Tris-HCl (pH 7.5), 90 mM KCl, 1.8 mM MgCl 2 , 0.2 mM TCEP, 9% glycerol, 0.11 mg/mL BSA, 2.2% NP-40 and 0.02 mM of ZnCl 2 . In the experiments we used 75 nM of the ds−DNAs and a total incubation volume of 20 μL. After incubation for 30 min products were resolved by PAGE using a 10% non-denaturing polyacrylamide gel and 0.5× TBE buffer for 40 min at 20 ºC, and analyzed by staining with SyBrGold (Molecular Probes: 5 μL in 50 mL of 1× TBE) for 10 min. and visualized by fluorescence. 5x TBE buffer (0.445M Tris, 0.445 M Boric acid). 
Fluorescence Anisotropy
Measurements were made with a Jobin-Yvon Fluoromax-3, (DataMax 2.20) coupled to a Wavelength Electronics LFI−3751 temperature controller, using the following settings: integration time: 2.0 s; excitation slit width: 5.0 nm; emission slit width: 20.0 nm; excitation wavelength 559 nm; emission wavelength 585 nm.
TMR-A or TMR-B (TMR-5'-GCG CTCTCAATTATGA CGCG-3' or TMR-5'-CGCG TCATCAGCGAGAG CGC-3', only one strand shown) (5μL, 5 μM), and calf thymus DNA (50 μM in base pairs) were added to 995 μL of Tris-HCl buffer 20 mM pH 7.5, 100 mM NaCl, 0.02 mM of ZnCl 2 , and the anisotropy was measured. Aliquots of a stock solution in water of the peptide BR(Hk)GAGA (12.5 μM) were successively added to this solution, and the anisotropic value was recorded after each addition. 
CD measurements
Circular Dichroism experiments were made with a Jasco-715 coupled with a thermostat Nestlab RTE-111. The settings used were: Acquisition range: 300-195nm; band width: 2.0 nm; resolution: 0.2 nm; accumulation: 5 scans; sensitivity 10 mdeg; response time: 0.25 s, speed: 100 nm/min. Measurements were made in a 2 mm cell at 20 ºC. Samples contained 10 mM phosphate buffer pH 7.5 and 100 mM of NaCl, 5 μM peptide and 5 μM of corresponding dsDNA (when present).
The mixtures were incubated for 5 min before registering. The CD spectra of the peptides (when measured in the presence of DNA) were calculated as the difference between the spectrum of the peptide/DNA mixture and the measured spectrum of a sample of the DNA oligonucleotide. The spectra are the average of 5 scans and were processed using the "smooth" macro implemented in the program Kaleidagraph (v 3.5 by Synergy Software).
Cellular internalization studies
Vero cells growing on glass coverslips were incubated in PBS containing 5 µM of TMR-BR(Hk)GAGA for 30 min. Then they were washed twice with PBS and observed in vivo in a fluorescence microscope equipped with adequate filters and differential interference contrast (DIC) microscopy. Digital pictures of the different samples were taken under identical conditions of gain and exposure.
